Abstract:G protein-coupled receptors (GPCRs) allow cells to respond to chemical and sensory stimuli through generation of second messengers, such as cyclic AMP (cAMP), which in turn mediate a myriad of processes, including cell survival, proliferation, and differentiation. In order to gain deeper insights into the complex biology and physiology of these key cellular pathways, it is critical to be able to globally map the molecular factors that shape cascade function. Yet, to this date, efforts to systematically identify regulators of GPCR/cAMP signaling have been lacking. Here, we combined genome-wide screening based on CRISPR interference with a novel sortable transcriptional reporter that provides robust readout for cAMP signaling, and carried out a functional screen for regulators of the pathway. Due to the sortable nature of the platform, we were able to assay regulators with strong and moderate phenotypes by analyzing sgRNA distribution among three fractions with distinct reporter expression. We identified 45 regulators with strong and 50 regulators with moderate phenotypes not previously known to be involved in cAMP signaling. In follow-up experiments, we validated the functional effects of seven newly discovered mediators (NUP93, PRIM1, RUVBL1, PKMYT1, TP53, SF3A2, and HRAS), and showed that they control distinct steps of the pathway. Thus, our study provides proof of principle that the screening platform can be applied successfully to identify bona fide regulators of GPCR/second messenger cascades in an unbiased and high-throughput manner, and illuminates the remarkable functional diversity among GPCR regulators.Cells sense and respond to changes in their surrounding environment through G protein-coupled receptors (GPCRs) and their associated cascades. The proper function of these pathways is essential to human physiology, and GPCRs have become a prime target for drug development for a range of human diseases. Therefore, it is of utmost importance to be able to map how these pathways operate to enable cells to fine-tune their responsiveness. Here, we describe a screening approach that we have devised to systematically identify regulators of GPCR function. We have developed a sortable reporter system and coupled that with silencing of genes across the entire human genome in order to uncover a range of novel mediators of GPCR activity. We characterize a few of these new regulators and show that they function at different steps of the cascade. Therefore, this study serves as proof of principle for the new screening platform. We envision that the approach can be used to dissect additional dimensions of GPCR function, including regulators of drug-specific responses, functional characterization of receptor features, and identification of novel drugs, and thus advance a genome-scale understanding of these critical pathways.

An engineered trafficking biosensor reveals a role for DNAJC13 in DOR downregulation

Using <i>C</i>. <i>elegans</i> Genetics to Identify Regulators of -Opioid Receptor Signaling

Illuminating GPCR trafficking

Genetic Behavioral Screen Identifies an Orphan Anti-Opioid System.

Retromer Opposes Opioid-Induced Downregulation of the Mu Opioid Receptor

A spatiotemporally resolved GPCR interactome reveals novel mediators of receptor agonism

Post‐endocytic Fates of Δ‐opioid Receptor Are Regulated by GRK2‐mediated Receptor Phosphorylation and Distinct Β‐arrestin Isoforms

Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment

Profiling the proximal proteome of the activated μ-opioid receptor

Identification of 1,3,8-Triazaspiro[4.5]Decane-2,4-Dione Derivatives as a Novel δ Opioid Receptor-Selective Agonist Chemotype

Identification of Novel Regulators for GPCR‐signaling via Genome‐wide Analysis

Heterologous Activation of Protein Kinase C Stimulates Phosphorylation of Δ-Opioid Receptor at Serine 344, Resulting in Β-Arrestin- and Clathrin-mediated Receptor Internalization

Design, Synthesis, and Characterization of New δ Opioid Receptor-Selective Fluorescent Probes and Applications in Single-Molecule Microscopy of Wild-Type Receptors

A high-throughput CRISPR interference screen for dissecting functional regulators of GPCR/cAMP signaling

Opioid receptors reveal a discrete cellular mechanism of endosomal G protein activation

G Protein–Coupled Receptor (GPCR) Expression in Native Cells: “Novel” endoGPCRs as Physiologic Regulators and Therapeutic Targets

EGF transregulates opioid receptors through EGFR-mediated GRK2 phosphorylation and activation

Ligand Efficacy Modulates Conformational Dynamics of the Μ-Opioid Receptor

Descriptive molecular pharmacology of the δ opioid receptor (DOR): A computational study with structural approach

Establishing the Framework to Evaluate Negative Modulators of Mu Opioid Receptor Signaling in Cells

Identification of Cytisine Derivatives as Agonists of the Human Delta Opioid Receptor by Supercomputer-Based Virtual Drug Screening and Transcriptomics